HOMEProfessor Lay Myint Yoshida

Faculty

Professor Lay Myint Yoshida

Speciality / Research theme / Keywords
Pediatric infectious diseases, Pneumonia, Dengue, HIV drug resistance, Tropical infectious diseases
Supervision
Masters Programme

Qualifications

M.B.B.S., M.Med.Sc., Ph.D

Personal/work Web page addresses

http://www.tm.nagasaki-u.ac.jp/pediatric/member/laymyint_en.html

Research gate or Linked-in account links

https://www.researchgate.net/profile/Lay_Myint_Yoshida

Affiliation(s)

Pediatric Infectious Diseases Department, Institute of Tropical Medicine, Nagasaki University

Background

  • 2016～up to now Professor, Institute of Tropical Medicine, Nagasaki University
  • 2010～2016 Asso.Professor, Institute of Tropical Medicine, Nagasaki University2006-2010: Assist.Professor, Institute of Tropical Medicine, Nagasaki University
  • 1999-2006: Research Fellow, AIDS Research Center, National Institute of Infectious Diseases, Tokyo
  • 1994-1999: Senior Researcher, Department of Medical Research, Myanmar
  • 1990-1994: Medical Doctor, Yangon General Hospital, Yangon, Myanmar<

Teaching

Occasionally give lectures and supervise for MTM, PhD students

Research

Pneumococcal Conjugate Vaccine reduced dosing schedule study in Nha Trang VietnamPediatric Acute Respiratory Infection Surveillance in central Vietnam Population based cohort study on infectious diseases in Nha Trang, central Vietnam Birth cohort study in Nha Trang, central Vietnam Evaluation of Hib vaccine effect on pneumonia in Vietnam HIV drug resistant studies in Vietnam, Thailand and Japan

The country/countries where you work currently

  • Japan
  • Vietnam

Five MOST IMPORTANT/INTERESTING recent publications

  1. Adewuyi O’, Balogun MS, Otomaru H, Abimiku A, Ahumibe AA, Ilori E, Luong QA, Mba N, Avong JC, Olaide J, Okunromade O, Ahmad A, Akinpelu A, Ochu CL, Olajumoke B, Abe H, Ihekweazu C, Ifedayo A, Toizumi M, Moriuchi H, Yanagihara K, Idris J, Yoshida LM. Molecular Epidemiology, Drug-Resistant Variants, and Therapeutic Implications of Hepatitis B Virus and Hepatitis D Virus Prevalence in Nigeria: A National Study.  Pathogens. 2025; 14(1):101. 
  2. Yoshida LM, Toizumi M, Nguyen HAT, Quilty BJ, Lien LT, Hoang LH, Iwasaki C, Takegata M, Kitamura N, Nation ML, Hinds J, van Zandvoort K, Ortika BD, Dunne EM, Satzke C, Do HT, Mulholland K, Flasche S, Dang DA. Effect of a Reduced PCV10 Dose Schedule on Pneumococcal Carriage in Vietnam. N Engl J Med. 2024; 391(21):1992-2002.
  3. Otomaru H, Nguyen HAT, Vo HM, Toizumi M, Le MN, Mizuta K, Moriuchi H, Bui MX, Dang DA, Yoshida LM. A decade of human metapneumovirus in hospitalized children with acute respiratory infection: molecular epidemiology in central Vietnam, 2007-2017. Sci Rep. 2023; 13(1):15757.
  4. Toizumi M, Satoh C, Quilty BJ, Nguyen HAT, Madaniyazi L, Le LT, Ng CFS, Hara M, Iwasaki C, Takegata M, Kitamura N, Nation ML, Satzke C, Kumai Y, Do HT, Bui MX, Mulholland K, Flasche S, Dang DA, Kaneko K, Yoshida LM.  Effect of pneumococcal conjugate vaccine on prevalence of otitis media with effusion among children in Vietnam. Vaccine. 2022; 40(36):5366-5375.
  5. Li Y, Wang X, Blau DM, Caballero MT, et al, Yoshida LM, Yung CF, Zar HJ; Respiratory Virus Global Epidemiology Network; Nair H; RESCEU investigators.  Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis. Lancet. 2022; 399(10340):2047-2064.

Message

Severe pediatric infectious diseases such as pneumonia, diarrhea and dengue are the main cause of under-five mortality and morbidity globally. These can be prevented by preventive measures such as vaccines, and early recognition and treatment of risk groups. We conduct population based cohort and intervention studies to provide better preventive measure and treatment for sever pediatric infectious diseases in the tropics.

PAGE TOP